KATHLEEN TARPY: Open Payments
NPI 1053748491 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,253 in 61 payments from 12 companies in 2025. Trend: 2023 $1,025 · 2024 $849 · 2025 $1,253
Food & beverage: $1,253
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $258 |
| Madrigal Pharmaceuticals | 6 | $196 |
| Janssen Biotech, Inc. | 3 | $168 |
| Ardelyx, Inc. | 6 | $130 |
| Regeneron Healthcare Solutions, Inc. | 4 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| Ipsen Biopharmaceuticals, Inc | 4 | $96 |
| GENZYME CORPORATION | 2 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $43 |
| QOL Medical, LLC | 1 | $33 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, IBSRELA, CREON, IQIRVO, RINVOQ, ENTYVIO.
Industry payments across SC — which companies pay providers there.
